path4194-sup-0001-AppendixS1.docapplication/unknown1613KSupplementary materials and methods
path4194-sup-0002-FigureS1.docWord document69KSchematic of the HPPCn transgene constructs used for microinjection.
path4194-sup-0003-FigureS2.docWord document93KIdentification of transgenic founder lines.
path4194-sup-0004-FigureS3.docWord document124KDetection of HPPCn by western blotting and Q-PCR.
path4194-sup-0005-FigureS4.docWord document428KGross and microscopic observation of transgenic mice and negative controls.
path4194-sup-0006-FigureS5.docWord document688KPrimary rat hepatocytes were infected with either Ad-SphK1 or the control vector Ad-GFP, Ad-null at different MOI.
path4194-sup-0007-FigureS6.docWord document270KBinding of rhHPPCn to LX-2 cells.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.